Research Institute for Tropical Medicine, Filinvest Corporate City, 9002 Research Dr, Alabang, Muntinlupa, 1781 Metro Manila, Philippines.
GSK, 23 Rochester Park, 139234 Singapore, Singapore.
Int J Infect Dis. 2020 Aug;97:38-46. doi: 10.1016/j.ijid.2020.05.062. Epub 2020 May 22.
Once symptoms appear, rabies is almost always fatal and accounts for 200-300 deaths annually in the Philippines. Available rabies vaccines can be administered either in pre- exposure prophylaxis (PrEP) or post-exposure prophylaxis (PEP). After exposure, PrEP-immunized individuals require fewer doses of PEP and no rabies immunoglobulin.
A static decision-tree model was developed to assess cost-effectiveness of a PrEP+PEP program vs PEP alone. Philippines-specific data for people seeking medical advice at the Research Institute for Tropical Medicine between July 2015 and June 2016 were used in the model, together with data from published literature.
Over a 20-year period, in a cohort of 1 million 5-year-old children in the Philippines, PrEP+PEP was expected to prevent 297 deaths compared with PEP alone. From both payer and societal perspectives, the resulting incremental cost-effectiveness ratios were 36 035 (US$759; 2016 US$ conversion) and 18 663 (US$393) Philippine Pesos (PHP) - quality-adjusted life-years gained - respectively, which are both below the willingness-to-pay threshold of PHP140 255 (US$2 953).
These data suggest that a universal PrEP program targeting 5-year-olds would be cost-effective in the Philippines.
在菲律宾,一旦出现症状,狂犬病几乎总是致命的,每年导致 200-300 人死亡。现有的狂犬病疫苗可以用于暴露前预防(PrEP)或暴露后预防(PEP)。暴露后,接受 PrEP 免疫的个体需要更少剂量的 PEP 和不需要狂犬病免疫球蛋白。
开发了一个静态决策树模型,以评估 PrEP+PEP 方案与单独 PEP 的成本效益。该模型使用了 2015 年 7 月至 2016 年 6 月期间在热带医学研究所寻求医疗建议的人群的菲律宾特定数据,并结合了已发表文献中的数据。
在菲律宾的 100 万 5 岁儿童队列中,在 20 年的时间内,PrEP+PEP 预计将预防 297 例死亡,而单独使用 PEP 则不会。从支付方和社会角度来看,增量成本效益比分别为 36035 美元(759 美元;2016 年美元换算)和 18663 菲律宾比索(PHP)(393 美元)每获得一个质量调整生命年,均低于 PHP140255(2953 美元)的支付意愿阈值。
这些数据表明,针对 5 岁儿童的普遍 PrEP 计划在菲律宾具有成本效益。